InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-13 · accession 0001104659-23-045715 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-04-14 2023-04-13 AMPH Liawatidewi Yakob EVP Corp Admin Center, Dir S - Sale+OE $41.56 -11.5K 75.7K -13% -$477.7K
D 2023-04-14 2023-04-13 AMPH Liawatidewi Yakob EVP Corp Admin Center, Dir M - OptEx $20.23 +11.5K 80.7K +17% +$232.5K
D 2023-04-14 2023-04-13 AMPH Liawatidewi Yakob EVP Corp Admin Center, Dir M - OptEx $0.00 -11.5K 5,497 -68% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-13 S D 6,494 $42.00 69,215 D — —
2 Common Common Stock 2023-04-13 S D 5,000 $41.00 75,709 D — —
3 Common Common Stock 2023-04-13 M A 11,494 $20.23 80,709 D — —
4 Derivative Employee Stock Option (right to buy) 2023-04-13 M D 11,494 $0.00 5,497 D $20.23 · — to 2029-03-15 11,494 Common Stock (F3) Shares subject to the option vest in four equal annual installments beginning on March 15, 2020.